{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:38:49Z","timestamp":1762101529606},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10753-014-9855-8","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T01:21:48Z","timestamp":1394068908000},"page":"1280-1288","source":"Crossref","is-referenced-by-count":12,"title":["Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension"],"prefix":"10.1007","volume":"37","author":[{"given":"Yavuz","family":"Pehlivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Dokuyucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davut Sinan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Orkmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Halil","family":"Turkbeyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Osman","family":"Ceribasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ediz","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyithan","family":"Taysi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"9855_CR1","doi-asserted-by":"crossref","unstructured":"Umar, S., et al. 2010. Novel approaches to treat experimental pulmonary arterial hypertension: a review. Journal of Biomedicine and Biotechnology.","DOI":"10.1155\/2010\/702836"},{"issue":"13","key":"9855_CR2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","volume":"114","author":"VV McLaughlin","year":"2006","unstructured":"McLaughlin, V.V., and M.D. McGoon. 2006. Pulmonary arterial hypertension. Circulation 114(13): 1417\u20131431.","journal-title":"Circulation"},{"issue":"5","key":"9855_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjp.0704924","volume":"137","author":"JJ Maguire","year":"2002","unstructured":"Maguire, J.J., and A.P. Davenport. 2002. Is urotensin-II the new endothelin? British Journal of Pharmacology 137(5): 579\u2013588.","journal-title":"British Journal of Pharmacology"},{"issue":"6750","key":"9855_CR4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","volume":"401","author":"RS Ames","year":"1999","unstructured":"Ames, R.S., et al. 1999. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401(6750): 282\u2013286.","journal-title":"Nature"},{"issue":"10","key":"9855_CR5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.peptides.2004.04.017","volume":"25","author":"AM Richards","year":"2004","unstructured":"Richards, A.M., and C. Charles. 2004. Urotensin II in the cardiovascular system. Peptides 25(10): 1795\u20131802.","journal-title":"Peptides"},{"issue":"2","key":"9855_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00210-001-0503-0","volume":"365","author":"V Camarda","year":"2002","unstructured":"Camarda, V., et al. 2002. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents. Naunyn-Schmiedeberg's Archives of Pharmacology 365(2): 141\u2013149.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"2","key":"9855_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjp.0703314","volume":"130","author":"MR MacLean","year":"2000","unstructured":"MacLean, M.R., et al. 2000. Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. British Journal of Pharmacology 130(2): 201\u2013204.","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"9855_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0703601","volume":"131","author":"JJ Maguire","year":"2000","unstructured":"Maguire, J.J., R.E. Kuc, and A.P. Davenport. 2000. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. British Journal of Pharmacology 131(3): 441\u2013446.","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"9855_CR9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/01.CIR.103.10.1378","volume":"103","author":"C Hillier","year":"2001","unstructured":"Hillier, C., et al. 2001. Effects of urotensin II in human arteries and veins of varying caliber. Circulation 103(10): 1378\u20131381.","journal-title":"Circulation"},{"issue":"4","key":"9855_CR10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pupt.2011.03.003","volume":"24","author":"YF Mei","year":"2011","unstructured":"Mei, Y.F., et al. 2011. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats. Pulmonary Pharmacology & Therapeutics 24(4): 386\u2013393.","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"2","key":"9855_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10753-012-9559-x","volume":"36","author":"AM Onat","year":"2013","unstructured":"Onat, A.M., et al. 2013. Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension. Inflammation 36(2): 405\u2013412.","journal-title":"Inflammation"},{"issue":"2","key":"9855_CR12","first-page":"85","volume":"50","author":"B Alexandru","year":"2001","unstructured":"Alexandru, B., and M.A. Bogdan. 2001. Monocrotaline induce pulmonary hypertension in animal models. Pneumologia 50(2): 85\u201389.","journal-title":"Pneumologia"},{"issue":"1","key":"9855_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.104.068320","volume":"311","author":"M Clozel","year":"2004","unstructured":"Clozel, M., et al. 2004. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System. Journal of Pharmacology and Experimental Therapeutics 311(1): 204\u2013212.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"9855_CR14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/jpet.105.094821","volume":"316","author":"M Clozel","year":"2006","unstructured":"Clozel, M., et al. 2006. The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. Journal of Pharmacology and Experimental Therapeutics 316(3): 1115\u20131121.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"9855_CR15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/jappl.1981.51.4.1047","volume":"51","author":"RB Stinger","year":"1981","unstructured":"Stinger, R.B., et al. 1981. Catheterization of the pulmonary artery in the closed-chest rat. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 51(4): 1047\u20131050.","journal-title":"Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology"},{"key":"9855_CR16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin, V.V., S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, J.R. Lindner, American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association, et al. 2009. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the AmericanCollege of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. Journal of the American College of Cardiology 53: 1573\u20131679.","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"9855_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5830\/CVJA-2010-088","volume":"21","author":"MR Essop","year":"2010","unstructured":"Essop, M.R. 2010. Contemporary insights into the pathogenesis, diagnosis and therapy of pulmonary arterial hypertension. Cardiovascular Journal of Africa 21(6): 334\u2013337.","journal-title":"Cardiovascular Journal of Africa"},{"issue":"6","key":"9855_CR18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"DJ Stewart","year":"1991","unstructured":"Stewart, D.J., et al. 1991. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Annals of Internal Medicine 114(6): 464\u2013469.","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"9855_CR19","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","volume":"120","author":"C Rubens","year":"2001","unstructured":"Rubens, C., et al. 2001. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120(5): 1562\u20131569.","journal-title":"Chest"},{"issue":"5","key":"9855_CR20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.peptides.2007.09.012","volume":"29","author":"P Papadopoulos","year":"2008","unstructured":"Papadopoulos, P., N. Bousette, and A. Giaid. 2008. Urotensin-II and cardiovascular remodeling. Peptides 29(5): 764\u2013769.","journal-title":"Peptides"},{"issue":"7","key":"9855_CR21","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm901294u","volume":"53","author":"BE Maryanoff","year":"2010","unstructured":"Maryanoff, B.E., and W.A. Kinney. 2010. Urotensin-II receptor modulators as potential drugs. Journal of Medicinal Chemistry 53(7): 2695\u20132708.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"23","key":"9855_CR22","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1021\/jm900683d","volume":"52","author":"EC Lawson","year":"2009","unstructured":"Lawson, E.C., et al. 2009. Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits. Journal of Medicinal Chemistry 52(23): 7432\u20137445.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"9855_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.ATV.0000154279.98244.eb","volume":"25","author":"T Djordjevic","year":"2005","unstructured":"Djordjevic, T., et al. 2005. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 25(3): 519\u2013525.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"9855_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00380-003-0739-3","volume":"19","author":"J Qi","year":"2004","unstructured":"Qi, J., et al. 2004. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart and Vessels 19(2): 81\u201388.","journal-title":"Heart and Vessels"},{"issue":"2","key":"9855_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1203\/PDR.0b013e3181c345ea","volume":"67","author":"CM Simpson","year":"2010","unstructured":"Simpson, C.M., et al. 2010. Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome. Pediatric Research 67(2): 150\u2013157.","journal-title":"Pediatric Research"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-9855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-014-9855-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-9855-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:32:25Z","timestamp":1565227945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-014-9855-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9855"],"URL":"https:\/\/doi.org\/10.1007\/s10753-014-9855-8","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,7]]}}}